BIOGRAPHICAL SKETCH
|
|
|
||||||||
|
Gregory Chaljub, M.D. Professor of Radiology (T),
Neuroradiology Section Director, Executive Vice Chairman
|
|
Publications and Papers: (last 2 years or 5 most
recent)
1.
Oto
A, Eltorky MA, Dave A,
2.
Oto
A, Ernst RD, Mileski WJ, Nishino TK, Le O, Wolfe GC, Chaljub G: Localization of appendix
with MDCT and influence of findings on choice of appendectomy incision.
American Journal of Roentgenology, 187; 987-990:
2006.
3.
Oto
A, Srinivasan P, Ernst R, Koroglu
M, Cesani F, Nishino T, Chaljub G:
Revisiting MRI for appendix location during pregnancy. American Journal of Roentgenology 186 (3): 883-887; March 2006.
4.
Dave
A, Shah RK, Chaljub G, Miles BJ,
Hernandez JA, Swischuk LE: Benign destructive lesions affecting the posterior
elements of the pediatric spine. Contemporary Diagnostic Radiology, Vol. 29
(22); October 31, 2006.
5.
Camacho
AC, Chaljub G, Uribe
T, Patterson JT, Swischuk LE: MR imaging of pediatric posterior fossa tumors.
Contemporary Diagnostic Radiology, Vol. 30 (14); July 1, 2007.
Exhibits: (last
2 years)
1.
Ethridge
KP, Chaljub G, Shah RK, Hernandez
JA, Swischuk LE:
Benign conditions afflicting the posterior elements of the pediatric
spine: a pictorial essay emphasizing MR and CT imaging. 105th Annual Meeting of the
American Roentgen Ray Society,
2.
Dave
A, Oto A, Eltorksy M, Ernst R, Chaljub G, Nealon W: CT findings
mimicking pancreatic neoplasms in patients with chronic
pancreatitis: histolopathologic
correlation. 91st Scientific
Assembly and Annual Meeting of the Radiological Society of North America, Chicago,
IL, Nov. 27 Dec. 2, 2005.
3.
Rao N, Sanguineti G, Chaljub G, Newlands S, Markowitz
A, Pena J: Neck levels that are negative on initial CT do not need to be
dissected. American Society for Therapeutic Radiology and Oncology Annual Meeting,
4.
Oto
A, Ernst R, Jesse MK, Ott L, Riascos
R, Chaljub G, Saade
G: MR imaging of the cystic adnexal lesions during
pregnancy. 107th Annual Meeting of the
American Roentgen Ray Society,
Research Grants:
1.
CNS/HIV
Anti-Retroviral Therapy Effect Research (CHARTER) Principal investigator: Igor Grant, Dr. Gelman
is PI on
2.
A
24-month double-blind, randomized, multicenter,
placebo controlled, parallel-groups study comparing the efficacy and safety of
0.5 mg and 1.25 mg fingolimod (FTY720) administered
orally once daily versus placebo in patients with relapsing-remitting multiple
sclerosis; Protocol No. CFTY720D2309; UTMB Principal Investigator: Dr. Robert
Glenn Smith (Neurology); UTMB Sub-Investigator (Neuro Brain Portion); Dr. Gregory Chaljub. Sponsored by: Novartis.
3.
ACRIN
6677
Areas of Interest:
|
Other Areas of Interest: |
· Neuroradiology expertise in MRI of the CNS
|
·
Residency training / teaching |
|
·
Musculoskeletal MR Imaging |
|